Страна: САЩ
Език: английски
Източник: NLM (National Library of Medicine)
LIDOCAINE (UNII: 98PI200987) (LIDOCAINE - UNII:98PI200987)
St. Mary's Medical Park Pharmacy
TOPICAL
PRESCRIPTION DRUG
Anesthetic for relief of pain at site of injury; relief of musculoskeletal pain and soreness; pain from neuropathy; local medical procedures, injections and vaccines; relief of pruritis, pruritic eczema, abrasions, minor burns, insect bites, pain, soreness and discomfort due to pruritis ani, pruritis vulvae, hemorrhoids, anal fissures and similar conditions of the skin and mucous membranes. Lidocaine Hydrochloride USP is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type or to other components of LidoRx 3%. Do not use LidoRx 3% on traumatized mucosa or in the presence of secondary bacterial infection of the area of proposed application. Teratogenic Effects. Pregnancy Category B. Reproduction studies have been performed in rats at doses up to 6.6 times the human dose and have revealed no evidence of harm to the fetus caus
LiDORx® 3% (Lidocaine HCl USP 3%): Cartons 0.33 oz (9.5g) 10mL Airless Pump - NDC 60760-408-10 for 1 Carton 1.01 oz (28.5g) 30mL Airless Pump - NDC 60760-408-30 for 1 Carton 3.04 oz (86g) 90mL Airless Pump - NDC 60760-408-90 for 1 Carton STORE AND DISPOSE OF THIS AND ALL MEDICATIONS OUT OF REACH OF CHILDREN AND PETS. All prescriptions using this product shall be pursuant to state statutes as applicable. This product may be administered under a physician’s supervision. There are no implied or explicit claims on the therapeutic equivalence. Store at 25ºC (77ºF); excursions permitted to 15º-30ºC (59º-86º F). See USP Controlled Room Temperature. Protect from freezing. Manufactured for: Gensco Pharma 8550 NW 33rd Street Miami, FL 33122.
unapproved drug other
LIDO RX- LIDOCAINE GEL ST. MARY'S MEDICAL PARK PHARMACY _Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been_ _approved by FDA. For further information about unapproved drugs, click here._ ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE LIDO SEE FULL PRESCRIBING INFORMATION FOR SAFETY AND EFFICACY DATA AND INITIAL U.S. APPROVAL RECENT MAJOR CHANGES N/A INDICATIONS AND USAGE THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE PLEASE SEE FULL PRESCRIPTION INFORMATION (1) LiDORx® 3% is an Amide type Local Anesthetic indicated for: Relief of pain, soreness, abrasions, minor burns, insect bites and discomfort due to pruritus, pruritic eczemas, pruritus ani, pruritus vulvae, hemorrhoids, anal fissures, and similar conditions of the skin and mucous membranes. (1) DOSAGE AND ADMINISTRATION Apply 1-4 pumps to the affected area three or four times daily not to exceed 16 pumps in twenty-four hours (24 Hrs) or as directed by a physician. As a topical anesthesic, apply an adequate amount for the desired procedure to the target area 10 minutes prior to initiation of procedure. (2) CONTRAINDICATIONS Traumatized mucosa, secondary bacterial infection of the area of proposed application and known hypersensitivity to any of the components. Lidocaine Hydrochloride USP is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type. (4) WARNINGS AND PRECAUTIONS For External Use Only. Avoid Contact with Eyes. If irritation or sensitivity occurs or infection appears, discontinue use and institute appropriate therapy. LiDORx® 3% should be used with caution in ill, elderly, debilitated patients and children who may be more sensitive to the systemic effects of Lidocaine Hydrochloride USP. Methemoglobinemia Warning: Cases of methemoglobinemia have been reported in association with local anesthetic use. Although all patients are at risk for methemoglobinernia, Прочетете целия документ